AU2018230262B2 - Eye drops for treatment of irritation not due to infection - Google Patents

Eye drops for treatment of irritation not due to infection Download PDF

Info

Publication number
AU2018230262B2
AU2018230262B2 AU2018230262A AU2018230262A AU2018230262B2 AU 2018230262 B2 AU2018230262 B2 AU 2018230262B2 AU 2018230262 A AU2018230262 A AU 2018230262A AU 2018230262 A AU2018230262 A AU 2018230262A AU 2018230262 B2 AU2018230262 B2 AU 2018230262B2
Authority
AU
Australia
Prior art keywords
glycerol
treatment
irritation
disclose
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018230262A
Other languages
English (en)
Other versions
AU2018230262A1 (en
Inventor
Shabtay Dikstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resdevco Research and Development Co Ltd
Original Assignee
Resdevco Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resdevco Research and Development Co Ltd filed Critical Resdevco Research and Development Co Ltd
Publication of AU2018230262A1 publication Critical patent/AU2018230262A1/en
Application granted granted Critical
Publication of AU2018230262B2 publication Critical patent/AU2018230262B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2018230262A 2017-03-05 2018-02-19 Eye drops for treatment of irritation not due to infection Active AU2018230262B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762467139P 2017-03-05 2017-03-05
US62/467,139 2017-03-05
PCT/IL2018/050184 WO2018163151A1 (en) 2017-03-05 2018-02-19 Eye drops for treatment of irritation not due to infection

Publications (2)

Publication Number Publication Date
AU2018230262A1 AU2018230262A1 (en) 2019-09-26
AU2018230262B2 true AU2018230262B2 (en) 2024-01-18

Family

ID=61656085

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018230262A Active AU2018230262B2 (en) 2017-03-05 2018-02-19 Eye drops for treatment of irritation not due to infection

Country Status (14)

Country Link
US (2) US11033513B2 (enExample)
EP (2) EP4385565A3 (enExample)
JP (1) JP7258778B2 (enExample)
KR (1) KR102652879B1 (enExample)
CN (1) CN110891555B (enExample)
AU (1) AU2018230262B2 (enExample)
BR (1) BR112019018367A2 (enExample)
CA (1) CA3055523C (enExample)
ES (1) ES3036888T3 (enExample)
IL (1) IL269133B2 (enExample)
MX (1) MX388961B (enExample)
PL (1) PL3592339T3 (enExample)
RU (1) RU2019130955A (enExample)
WO (1) WO2018163151A1 (enExample)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
JP3093661B2 (ja) * 1995-10-12 2000-10-03 大塚製薬株式会社 眼疾患治療剤
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
IL120005A (en) * 1997-01-14 2000-08-31 Ramot University Authority Of Pharmaceutical compositions for the treatment of the eye
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
DE102005055275A1 (de) 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
IL212725A (en) * 2011-05-05 2016-06-30 Resdevco Res And Dev Co Glycerol Preparation for Non-surgical Conjunctivochalysis
ES2751248T3 (es) * 2011-11-24 2020-03-30 Toyo Sugar Refining Co Ltd Agente protector queratoconjuntival o agente inhibidor de trastornos queratoconjuntivales
US9278132B2 (en) 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARAGONA P. et al., "Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren’s syndrome patients", BRITISH JOURNAL OF OPTHALMOLOGY, 2002, vol 83, no. 8, pages 879-884 *

Also Published As

Publication number Publication date
EP3592339C0 (en) 2025-04-30
WO2018163151A1 (en) 2018-09-13
AU2018230262A1 (en) 2019-09-26
PL3592339T3 (pl) 2025-09-01
IL269133A (en) 2019-11-28
ES3036888T3 (en) 2025-09-25
US11426361B2 (en) 2022-08-30
EP4385565A3 (en) 2024-08-21
KR102652879B1 (ko) 2024-03-29
JP2020509092A (ja) 2020-03-26
RU2019130955A3 (enExample) 2021-06-24
RU2019130955A (ru) 2021-04-07
MX388961B (es) 2025-03-20
US20190388361A1 (en) 2019-12-26
EP4385565A2 (en) 2024-06-19
IL269133B2 (en) 2024-09-01
CA3055523A1 (en) 2018-09-13
EP3592339B1 (en) 2025-04-30
KR20190129065A (ko) 2019-11-19
IL269133B1 (en) 2024-05-01
EP3592339A1 (en) 2020-01-15
CN110891555B (zh) 2023-12-26
US11033513B2 (en) 2021-06-15
US20210186892A1 (en) 2021-06-24
JP7258778B2 (ja) 2023-04-17
MX2019010471A (es) 2020-02-12
CA3055523C (en) 2024-10-01
BR112019018367A2 (pt) 2020-04-07
CN110891555A (zh) 2020-03-17

Similar Documents

Publication Publication Date Title
RU2687275C2 (ru) Слезозаменитель, содержащий гиалуронат натрия и карбоксиметилцеллюлозу
WO2010135731A1 (en) Preparations and methods for ameliorating or reducing presbyopia
JP7614069B2 (ja) ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP2005513106A (ja) ヘパリンを保有する眼薬剤
JP4999304B2 (ja) ヒアルロン酸又はその塩を含有する粘膜適用組成物
AU2018230262B2 (en) Eye drops for treatment of irritation not due to infection
CN110913867B (zh) 热凝胶化人工泪液
US8912166B2 (en) Eye drops for treatment of conjunctivochalasis
US20190151352A1 (en) Ophthalmic composition comprising a synergistic combination of glycogen and hyaluronic acid or a salt thereof
WO2023048174A1 (ja) 角膜疾患治療剤
Baklayan et al. Evaluation of aqueous humor concentrations of Istalol® and Betimol® following a single ocular instillation in rabbit eyes
HK1232464B (en) Therapeutic agent for keratoconjunctive disorder

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)